Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Tepotinib Study in Solid Tumors with c-MET Alterations
KCT0004498Phase 2Completed
- Sponsor
- Ministry of Health & Welfare
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tepotinib in Non-hematologic malignancy, sponsored by Ministry of Health & Welfare. Started Mar 2020; status: completed.
02
Drugs
tepotinib
03
Conditions
Non-hematologic malignancy
Beyond the preview
Go deeper on KCT0004498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0004498.